Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
F2G
company
About
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
- 251 - 500
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €24M
- Industries
- Biotechnology,Genetics,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 251 - 500
- Operating Status
- Active
F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€24M $30M £6.30M
F2G has raised a total of
€24M $30M £6.30M
in funding over 2 rounds. Their latest funding was raised on
Nov 22, 2018 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 22, 2018 | Debt Financing | €24M | 1 |
European Investment Bank
|
— | Detail |
| Sep 5, 2012 | Series Unknown | $30M | 1 | — | — | Detail |
| Aug 18, 2008 | Series Unknown | £6.30M | 2 |
BankInvest Biomedical Venture
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
F2G has made 2 investments. Their most recent investment was on
Nov 17, 2022, when Heroic Story raised $6M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 17, 2022
Heroic Story
|
Seed | $6M | Cryptocurrency | — |
|
Apr 1, 2014
Flexport
|
Series A | $6.90M | Freight Service | — |
Investors
Number of Lead Investors
Number of Investors
2
3
F2G is funded by 3 investors.
European Investment Bank
and BankInvest Biomedical Venture
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Debt Financing |
|
BankInvest Biomedical Venture
|
Yes | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
